Cerevel Therapeutics Holdings Cash from Investing (TTM) Analysis

Cerevel Therapeutics Holdings Inc (CERE)

42.16 -0.14 (-0.33%) USD | NASDAQ | May 10, 16:00

42.16 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	-17.90M
December 31, 2023	73.72M
September 30, 2023	197.20M
June 30, 2023	-242.05M
March 31, 2023	-239.51M
December 31, 2022	-388.83M
September 30, 2022	-788.33M

Date	Value
June 30, 2022	-401.67M
March 31, 2022	-469.54M
December 31, 2021	-435.66M
September 30, 2021	-16.98M
June 30, 2021	-23.09M
March 31, 2021	-21.00M
December 31, 2020	-18.89M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-788.33M

Minimum

Sep 2022

197.20M

Maximum

Sep 2023

-199.47M

Average

-131.30M

Median

Cash from Investing (TTM) Benchmarks